NovaBay Pharmaceuticals, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
NovaBay Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q3 2024.
  • NovaBay Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $117K, a 3.54% increase year-over-year.
  • NovaBay Pharmaceuticals, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $552K, a 24.9% increase year-over-year.
  • NovaBay Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $543K, a 0.56% increase from 2022.
  • NovaBay Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $540K, a 13.7% increase from 2021.
  • NovaBay Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $475K, a 48.8% decline from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $552K $117K +$4K +3.54% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $548K $117K +$3K +2.63% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $545K $76K +$2K +2.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $543K $242K +$101K +71.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 $442K $113K -$31K -21.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $473K $114K -$30K -20.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $503K $74K -$37K -33.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $540K $141K +$5K +3.68% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 $535K $144K +$31K +27.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $504K $144K +$31K +27.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $473K $111K -$2K -1.77% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $475K $136K +$25K +22.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $450K $113K -$123K -52.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $573K $113K -$171K -60.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $744K $113K -$183K -61.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $927K $111K -$204K -64.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 $1.13M $236K -$86K -26.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $1.22M $284K -$40K -12.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $1.26M $296K -$28K -8.64% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $1.29M $315K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 $322K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $324K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $324K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.